CD147/basigin (BSG) is highly upregulated in many types of cancer, our previous study has found that CD147/BSG is highly expressed in head and neck squamous cell carcinoma (HNSCC) stem cells, but its role in HNSCC and the underlying mechanism is still unknown. In this study, we investigated the role of CD147 in the progression of HNSCC. Real-time PCR, western blot and immunohistochemistry were used to detect the expression of CD147 in total 189 HNSCC tissues in compared with normal tissues. In addition, we used proliferation, colony formation, cell cycle and apoptosis, migration and invasion as well as wound-healing assay to determine the biological roles of CD147 in HNSCC. Then, a xenograft model was performed to evaluate tumor-promoting and metastasis-promoting role of CD147 in HNSCC.
widely expressed on the surface of cancer cells. 6 Reports showed that CD147 was over-expressed in many types of cancer, such as human malignant melanoma, hepatocellular carcinoma, lung cancer, gastric cancer, breast cancer and so on. [7] [8] [9] [10] [11] [12] CD147 is also reported to involve in tumor progression, angiogenic function and immune response. 13, 14 Furthermore, many studies demonstrated that CD147 could stimulate the activation of nuclear factor kappa B (NF-kappa B) pathway. [15] [16] [17] The NF-kappa B pathway is reported to elevate cancer cell proliferation, metastasis and reduce cancer cell apoptosis. 11, 18 And the family of NF-kappa B transcription factors consists of RelA/p65, c-Rel, RelB, NF-κB1 (p50), and NF-κB2(p52) and are kept silenced in the cytoplasm. 11 When there are stimuli, the NF-kappa B complex degrades and p65 enters the nucleus to regulate their target genes. 19, 20 However, direct evidence for the crosslink between CD147 and the NF-kappa B pathway in HNSCC has been lacking.
In this study, we firstly investigated the expression patterns of 
| Cell culture
The human HNSCC cell lines HN4, HN6, HN30, SCC-9, SCC-25 and CAL 27 were obtained from the National Institutes of Health. Normal mucosa cells of gingival tissues were taken from patients with impacted teeth extraction. The Rca-T cell line was purified from tongue squamous cell carcinoma tissues induced by adding 4-nitroquinoline-1-oxide into Sprague-Dawley rats' drinking water. HN4, HN6, HN30, CAL 27 and Rca-T cells were cultured in Dulbecco's modified Eagle's medium (DMEM; GIBCO, USA), containing 10% fetal bovine serum (FBS; GIBCO), 100 units/mL penicillin and 100 μg/mL streptomycin at 37°C in a humidified 5% CO 2 atmosphere. SCC-9 and SCC-25 cells was cultured in DMEM/F12 media (GIBCO), containing 10% FBS (GIBCO), 100 units/mL penicillin and 100 μg/mL streptomycin at 37°C in a humidified 5% CO 2 atmosphere. Normal mucosa cells were cultured in Defined Keratinocyte-SFM with Growth Supplement (K-SFM; GIBCO) at 37°C in a humidified 5% CO 2 atmosphere.
| Immunohistochemistry
Tissues slides were deparaffinized, rehydrated, and then were heated with citric acid buffer for antigenic retrieval. After cooled at room temperature, the sections were submerged into 0.3% hydrogen per- A tissue microarray containing 101 HNSCC specimens and 10 normal tissues at Shanghai Ninth People's Hospital were used in this study. The immunohistochemistry (IHC) stain score is the sum of positive cell score and staining intensity score for each sample. The positive cell score were classified into five categories: 0%-25%, scored 1; >25%-50%, scored 2; >50%-75%, scored 3; >75%, scored 4. The staining intensity score was defined as 0, 1, 2, and 3. Finally, the above two scores were multiplied for an overall score (ranging from 1 to 12). A total score of 1-6 was considered low expression;
7-12 was considered high expression. 
| Immunofluorescence

| Lentivirus transfection
We silenced three sequences of the CD147 gene, namely, CD147-Homo-550 (siRNA), CD147-Homo-647 (siRNA) and CD147-Homo-702 (siRNA). We checked the efficiency of the three interference sequences and selected the interference of CD147-Homo-550
(siRNA), then packaged it as lentivirus to use in this study AACUCACGAAGAACCUGCUTT.
| Cell proliferation assay
Cells transfected with shCD147 or shNC were plated at a density of 1 × 10 3 cells per well in 96-well plates. CCK-8 kit (Dojindo, Japan) was used to determine the OD value at 450 nm after 2 hours following the kit instructions. All experiments were performed in triplicate, and the mean proliferation rate was reported.
| Colony formation assay
Cells transfected with shCD147 or shNC were plated at a density of F I G U R E 2 CD147 promoted the proliferation and reduced the apoptosis phenotype of HNSCC cells. (A) The knockdown rate of CD147 in HN4 and HN30 is shown. (B) Proliferation assays showed that proliferation was reduced in HN4 cells after transfected with shCD147 and negative control lentivirus. **P < 0.01, based on Student's t test. (C) Proliferation assays showed that proliferation was reduced in HN30 cells after transfected with shCD147 and negative control lentivirus. ***P < 0.001, based on Student's t test. (D) The negative control and shCD147 of HN4 and HN30 cells were performed by colony formation assay. **P < 0.01, ***P < 0.001, based on Student's t test. (E) Flow cytometry analysis of cell cycle progression in HN4 and HN30 cells were determined after transfected with shCD147 and negative control lentivirus. *P < 0.05, **P < 0.01, based on Student's t test. (F) Flow cytometry analysis of apoptosis in HN4 and HN30 cells were performed after transfected with shCD147 and negative control lentivirus. **P < 0.01, ***P < 0.001, based on Student's t test 
| Wound-healing assay
Cells transfected with shCD147 or shNC were cultured in 6-well plates in DMEM until 100% confluence. The cells were scraped with a P200 tip, washed with PBS and changed for fresh serum-free DMEM. Pictures were taken at 0, 12 and 24 hours for at least five non-overlapping fields.
| Cell cycle analysis
Cells transfected with shCD147 or shNC were cultured in serumfree DMEM overnight and replaced with DMEM containing 10% 
| Animal experiments
To evaluate the role of CD147 in tumor progression, 1 × 10 6 HN6-shNC or HN6-shCD147 cells in 100 μL serum-free DMEM were 
| Statistical analyses
The data were compiled using with SPSS 19.0 statistical software.
Values are presented as means ± SEM. The results of the real-time PCR, cell proliferation assays, cell cycle assays, colony formation assays, cell scratching assays, cell migration and invasion assays and cell apoptosis assays were compared using Student's t test. KaplanMeier survival analyses were used to analyse the relationship between CD147 level and the clinicopathologic features. The staining intensity score at 6 was considered to be median score: 1-6 was The Cox proportional hazards model was used for univariate and multivariate analyses. All experiments were performed in triplicate and a P-value <0.05 was considered statistically significant.
| RESULTS
| Upregulated CD147 expression was associated with aggressive clinicopathologic features and poor prognosis in HNSCC
To detect the role of CD147 in HNSCC, we searched for The
Cancer Genome Atlas (TCGA) dataset, and data showed that CD147 expression level was higher in various type of tumors ( Figure S1A ) and most patients in different tumors was with higher CD147 expression level ( Figure S1C ). In addition, the CD147 gene was expressed at high levels in HNSCC tissues compared with normal tissues (Figure S1B and D) . TCGA dataset also showed that high CD147 expression had a significantly low disease-free survival (DFS) probability (P = 0.026) in HNSCC, however, CD147 expression had no obvious difference with the OS probability (P = 0.21) in HNSCC ( Figure S1E and strong CD147 staining images from HNSCC patients compared with normal tissues ( Figure 1C ). As shown in Table 1, CD147 expression levels were significantly associated with gender, nodal status, differentiation and prognosis of HNSCC, but was not significantly associated with age, smoking, drinking and tumor size.
Kaplan-Meier was used to analysed the OS probability and DFS probability of HNSCC patients and the results revealed that patients with high CD147 expression had a significantly low OS probability and low DFS probability (both P < 0.0001) ( Figure 1D and E). The COX regression analyses revealed that CD147 expression was significantly correlated with poor OS in HNSCC patients and was an independent predictor of prognosis for patients with HNSCC ( Table 2 ).
| CD147 promoted the proliferation and reduced the apoptosis phenotype of HNSCC cells
To explore the role of CD147 in proliferation of HNSCC, we first analysed protein expression level of two normal mucosa cells and seven HNSCC cells. The results showed that relatively moderate to high CD147 expression levels were observed in HNSCC tumor cells, whereas low levels were observed in normal mucosa cells ( Figure S2A ). We then knocked down CD147 in HN4 and HN30 cells with GFP-tagged lentivirus. Western blot showed that endogenous CD147 expression was efficiently suppressed compared with negative control cells (Figure 2A and Figure S2B ). CD147 knockdown significantly reduced proliferation rate of HN4 (P < 0.01) and HN30 cells (P < 0.001) ( Figure 2B and C). In addition, colony formation capacities of HN4 (P < 0.001) and HN30 (P < 0.01) cells were significantly reduced compared with negative control cells ( Figure 2D ). Cell cycle arrest and apoptotic cells in HN4 and HN30
transfected with shNC and shCD147 were all consistent with these findings ( Figure 2E and F) . Taken together, we demonstrated that CD147 promoted proliferation and reduced apoptosis of HNSCC cells.
| CD147 promoted the migration and invasion phenotype of HNSCC cells
Based on the role of CD147 in the proliferation of HNSCC cells, we further detected the effect of CD147 on tumor migration and invasion. Scratch wound healing assays showed that CD147 knockdown significantly reduce the migration of HN4 and HN30 cells (both P < 0.01) ( Figure 3A ). In addition, migration and invasion assays were also associated with the results (Figure 3B and C) . Collectively, these data showed that CD147 promoted the migration and invasion phenotype of HNSCC cells. 
| CD147 expression was higher in lung metastasis tissues in vivo
To investigate the role of CD147 in lung metastasis, a total of 2 × 10 6 Rca-T cells were injected into the lateral tail vein of nude mice and mice were killed at 0, 1 day, 4 days, 1 week and 2 weeks respectively. Then the lungs were isolated and pictures were taken ( Figure 5A ). H&E staining revealed that the metastatic colony numbers in lungs at 1 week and 2 weeks were significantly higher compared to control groups ( Figure 5B ). Lung weight were also significantly elevated at 1 week (P < 0.01) and 2 weeks (P < 0.001),
but not significantly elevated at 1 day and 4 days compared with 0 day ( Figure 5C ). We further explored the CD147 expression level at different points, and the results demonstrated that CD147 expression levels were higher in lungs of 1 week (P < 0.001) and 2 weeks (P < 0.0001) compared with 0 day ( Figure 5D ). Therefore, we proposed that CD147 may take part in the metastatic clones formation in vivo. 
| DISCUSSION
Multimodality approaches have improved clinical outcome in HNSCC, including surgery, chemotherapy, radiotherapy and therapeutics targeted EGFR. 23, 24 However, there are still 50% of patients uncured, 4, 11 which suggested an urgent need to detect other predictable biomarkers in HNSCC.
As our previous study shown, CD147 is considered to be a HNSCC cell surface marker that could enhance the tumor initiation and progression. 5 Studies also demonstrated that CD147 had negative role in regulating in T cell-mediated immune responses and drugs targeting CD147 had anti-angiogenesis and anti-invasion activity. [25] [26] [27] [28] Our data determined that CD147 exerted positive effect on tumorigenicity and cancer progression of HNSCC both in vitro and in vivo. In addition, CD147 expression level is positively correlated with clinical outcome and tumor histological grade in HNSCC. Hence, CD147 might be predictable diagnosis target for HNSCC.
In addition, reports showed that CD147 is an important molecule that induced NF-kappa B pathway activated and cause increased cell proliferation and reduced cell apoptosis. 29 NF-kappa B signaling also activated recombinant human CD147 in cardiomyocytes. 15 Therefore, we investigate whether CD147 exerted its function through NF-kappa B pathway. We focused on NF-kappa B pathway for three reasons. First, many previous studies demonstrated the molecular link between CD147 and NF-kappa B pathway. 15, 29, 30 Second, NF-kappa B target several genes that are important for the inflammatory response, cell proliferation, adhesion, interaction with the microenvironment, as well as tumor growth and metastasis. [31] [32] [33] [34] Third, our previous study demonstrated that NFkappa B activity was significantly positively correlated with invasion and metastasis in HNSCC. 35 Inhibition of NF-kappa B activity suppressed cell migration in vitro and reduced the lung metastasis and lymph node metastasis in vivo. 35 In this study, CD147 knockdown was also correlated with reduced proliferation, migration and invasion, increased apoptosis of HNSCC cells, and suppressed tumor progression in vivo, which suggested that the role of CD147 was consistent with NF-kappa B in HNSCC. In addition, our study demonstrated that CD147 knockdown significantly impaired the TNF-α induced NF-kappa B activation. Therefore, we concluded that CD147 promoted tumor initiation and progression of HNSCC via NF-kappa B signaling.
The mechanisms underlying CD147 induced activation of NFkappa B in HNSCC were still not clear. Reports showed that different stimuli could activate the NF-kappa B signaling, including cytokine, growth factor, DNA damages and oncogenic stress. 11 The activation of NF-kappa B induced the formation of the IKK (IκB kinase) protein complex and some protein regulate the complex as IKK interactors, such as Hsp70, Hsp90. And some NF-kappa B targeted genes promote tumor growth, invasion and metastasis, such as MMP-9 and IL-6. 11, 30, 35, 36 There are reports shown that CD147 promoted the expression of MMP-9, which might be a mechanism that CD147 promoted tumor progression and invasion in HNSCC via regulating NF-kappa B signaling. 30 In addition, inhibition of CD147 by using the CD147 monoclonal antibody (5A12) was reported to reduce the proinflammatory cytokine production and thus suppressed the activation of NF-kappa B pathway. 29 Summarily, in this study, we identified CD147 as a tumor promotor in HNSCC cells and CD147 could act as an independent predictor for prognosis of patients with HNSCC. Furthermore, the loss of CD147 expression on cell surface might be a predictive therapeutic target. 27 However, there remains some problems that need to be 
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